Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 21 - Drugs for disorders of the muscular or neuromuscular system
Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287)
12/2003
12/04/2003CA2784937A1 Ccr9 inhibitors and methods of use thereof
12/04/2003CA2486853A1 Bis-aromatic alkanols
12/04/2003CA2486187A1 Kinase inhibitors
12/04/2003CA2485184A1 Methods for the identification of ikkalpha function and other genes useful for treatment of inflammatory diseases
12/04/2003CA2485166A1 Substituted pyrimidinone and pyridinone compounds
12/04/2003CA2484822A1 Novel thiophene amidines, compositions thereof, and methods of treating complement-mediated diseases and conditions
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2484000A1 Neutralizing human anti-igfr antibody
12/03/2003EP1367055A1 Isoquinolinyl carboxamides and their use as anticonvulsants
12/03/2003EP1366771A2 Use of the neurotoxic compnent of botulinum toxins as a medicament
12/03/2003EP1366770A2 Use of botulinum toxin for treating muscle-associated pain
12/03/2003EP1366162A2 Putative proteins and nucleic acids encoding same
12/03/2003EP1366039A1 Piperazinylcarbonylquinolines and -isoquinolines
12/03/2003EP1366025A1 Agonists of beta-adrenoceptors
12/03/2003EP1366007A2 Compounds with high monoamine transporter affinity
12/03/2003EP1365800A2 Methods for using tetanus toxin for benificial purposes in animals (mammals)
12/03/2003EP1365798A2 Use of serp-1 in combination with an immunosuppressant for influencing inflammatory and immune reactions
12/03/2003EP1365778A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
12/03/2003EP1015437B1 Benzoxazine and benzothiazine derivatives and their use in pharmaceuticals
12/03/2003CN1460025A Immunomodulatory human MHC class Ôàí antigen-binding polypeptides
12/03/2003CN1129576C Phenyl heterocyclic compound used as epoxy enzyme-2 inhibitor
12/03/2003CA2431795A1 Topical and oral administration of a composition containing pelargonium graveolens for diagnosis and treatment of various neuralgias and other conditions
12/02/2003US6656971 Non-peptidic small organic compounds having an affinity for cyclophilin (CyP)-type immunophilins; inhibiting their peptidyl-prolyl isomerase activity; treating variety of medical conditions
12/02/2003US6656957 Pyridine derivatives
12/02/2003US6656939 Pyrazole compounds useful as protein kinase inhibitors
12/02/2003US6656475 Modulating growth of muscle or adipose tissue in eukaryotic organism using agent that affects myostatin signal transduction
11/2003
11/27/2003WO2003097658A2 Compounds and methods for inhibiting selectin-mediated function
11/27/2003WO2003097597A2 Indole derivatives and the use thereof as cb2 receptor ligands
11/27/2003WO2003097573A1 Amines that inhibit a mammalian anandamide transporter, and methods of use thereof
11/27/2003WO2003097564A2 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003WO2003097104A1 Treatment and prevention of tissue damage
11/27/2003WO2003097098A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003WO2003097082A2 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003WO2003097073A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/27/2003WO2003097071A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003WO2003097062A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003WO2003097024A1 Methods for the prevention and/or the treatment of neurological disorders
11/27/2003WO2003096980A2 Bicyclic modulators of androgen receptor function
11/27/2003WO2003062268A3 Corticotropin releasing factor receptor 2 agonists
11/27/2003WO2003053354A3 Fused cyclic modulators of nuclear hormone receptor function
11/27/2003WO2003053336A3 Methods for the treatment of peripheral neural and vascular ailments
11/27/2003WO2003039446A3 Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible no-synthase
11/27/2003WO2003029276A3 Copolymers for suppression of autoimmune diseases, and methods of use
11/27/2003WO2003020759A3 A caspase- 8 binding protein, its preparation and use
11/27/2003WO2003008443A3 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
11/27/2003WO2002092004A8 Use of hmg fragment as anti-inflammatory agents
11/27/2003WO2002057242A3 Urea derivatives as integrin alpha 4 antagonists
11/27/2003WO2002049625A3 Compounds that affect cd83 expression, pharmaceutical compositions comprising said compounds and methods for identifying said compounds
11/27/2003US20030220484 Modified ciliary neurotrophic factors
11/27/2003US20030220390 Carbocyclic oxy amines such as 2-benzylidene-6-dimethylamino methylcyclohexanone, used as analgesics
11/27/2003US20030220382 Amines such as 2-((2-N,N-di-n-pentylamino)-indan-5-yl)amino-5 -nitro-benzoic acid, administered for prophylaxis of Alzheimer's disease
11/27/2003US20030220375 N-biphenyl(substituted methyl) aminocycloalkane-carboxamide derivatives
11/27/2003US20030220372 Imidazole compounds as anti-inflammatory and analgesic agents
11/27/2003US20030220353 Useful as inhibitors of protein kinases, such as the enzyme Janus Kinase 3
11/27/2003US20030220341 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
11/27/2003US20030220335 Benzoxazines for use in the treatment of parkinson's disease
11/27/2003US20030220297 Phosphorus-containing compounds and uses thereof
11/27/2003US20030219898 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
11/27/2003US20030219875 Albumin fusion proteins
11/27/2003US20030219874 Comprises endothelial differentiation gene receptor proteins (EDG8) for monitoring receptivity to and/or diagnosing cancer, angiogenesis and inflammation
11/27/2003US20030219739 Comprises muscle protein for treating and preventing of muscle atrophy
11/27/2003US20030219439 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders
11/27/2003US20030219404 A therapeutic polypeptide drug conjugated with two chains of polyoxyethylene glycol, linked to a cyclohexane ring; high molecular weight, stability, nontoxic, sustained release
11/27/2003US20030219375 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003CA2486302A1 Methods for the prevention and/or the treatment of neurological disorders
11/27/2003CA2486147A1 Treatment of crohn's disease or psoriasis using anti-inteferon gamma antibodies
11/27/2003CA2486106A1 Compounds and methods for inhibiting selectin-mediated function
11/27/2003CA2485081A1 Pharmaceutical composition comprising a renin inhibitor, a calcium channel blocker and a diuretic
11/27/2003CA2484646A1 Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
11/27/2003CA2484631A1 Phenyl substituted imidazopyridines and phenyl substituted benzimidazoles
11/27/2003CA2484308A1 Substituted quinolone carboxylic acids, their derivatives, site of action, and uses thereof
11/27/2003CA2482756A1 Indole derivatives and the use thereof as cb<sb>2</sb> receptor ligands
11/27/2003CA2482746A1 Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders
11/26/2003EP1364952A1 Bicyclic nitrogenous fused-ring compound
11/26/2003EP1364949A1 Jnk inhibitor
11/26/2003EP1364653A1 Casoase 3 inhibitors
11/26/2003EP1364023A2 Method of diagnosing and treating cartilage disorders
11/26/2003EP1364010A2 Immunomodulatory polynucleotides and methods of using the same
11/26/2003EP1363914A1 Aryl substituted alkylcarboxylic acids as hypocholesterolemic agents
11/26/2003EP1363913A2 Salts of pyrimidine derivatives for use against coronary heart disease and atherosclerose
11/26/2003EP1363902A1 Chemical compounds
11/26/2003EP1363898A1 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363635A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
11/26/2003EP1363631A2 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/26/2003EP1363509A1 Compositions containing creatine and creatinine
11/26/2003EP0912601B1 Suppression of immune response via inhibition of cathepsin s
11/26/2003EP0605474B1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases
11/26/2003CN1458979A Modulating multiple lineage kinase proteins
11/26/2003CN1458929A Chemokine receptor binding heterocyclic compounds
11/25/2003US6653467 Antisense oligonucleotide selected from RNA or DNA, of given sequence, where each uracil is replaced with thymine; used to correct the shift of the reading frame; dystrophin
11/25/2003US6653466 Active principle comprises antisense oligonucleotide consisting of a 20 to 50-nucleotide sequence against exon 19 of dystrophin pre-mRNA
11/25/2003US6653347 For therapy
11/25/2003US6653312 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same
11/25/2003US6653310 For therapy of disease states mediated by the chemokine, Interleukin-8 (IL-8)
11/25/2003US6653301 For therapy of cancer, diabetes and Alzheimer's disease
11/25/2003US6653300 Pyrazole compounds useful as protein kinase inhibitors
11/20/2003WO2003095678A1 Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
11/20/2003WO2003095613A2 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/20/2003WO2003094861A2 Bis-benzimidazoles and related compounds as potassium channel modulators
11/20/2003WO2003070192A9 Compositions and methods for surrogate antibody modulation of an immune response and transport
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 233